1. United Kingdom Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Surgical Innovations Group plc

Surgical Innovations Group plc

SUN.L
Surgical Innovations Group plcGB flagLondon Stock Exchange
0.45
GBp
-0.05
- -
4.20MMarket Cap
Surgical Innovations Group plc
SUN.L
(London Stock Exchange)

Recent

price

0.45

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
0.02
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
12.91
0.01
Revenue per Share
- -
- -
- -
- -
-0.02
- -
- -
- -
- -
- -
- -
- -
- -
- -
-2.1
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-0.44
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.03
0.03
0.03
0.03
0.01
- -
0.01
0.01
0.01
0.01
- -
- -
- -
- -
0.41
- -
Book Value per Share
0.02
0.02
0.02
0.01
0.01
0.01
0.01
- -
0.01
0.01
0.01
- -
- -
- -
3.37
- -
Tangible Book Value per Share
376
393
402
405
431
485
488
638
783
790
835
937
933
933
1
895
Basic Weighted Avg Shares
7
8
8
7
4
5
6
9
11
11
6
9
11
12
12
12
Sales/Revenue/Turnover
27.59
23.24
17.32
3.32
-79.9
-36.12
7.7
6.87
3.16
-0.02
-37.43
-2.82
0.64
-4.89
-5.34
-7.57
Operating Margin (%)
1
1
1
1
1
1
1
2
2
4
2
1
1
1
2
1
Depreciation Expense
2
2
1
- -
-9
-2
1
- -
1
-3
-3
- -
- -
-1
-2
-1
Net Income, GAAP
- -
- -
44.36
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
25.38
22.86
8.98
1.71
-234.72
-37.18
11.76
5.58
6.61
-24.4
-51.76
-5
2.33
-4.24
-16.27
-7.71
Profit Margin (%)
5
4
5
3
5
4
3
4
5
4
6
4
4
3
2
2
Working Capital
1
1
1
1
4
3
- -
2
2
2
3
1
2
1
1
- -
LT Debt
11
13
14
13
6
4
6
14
14
12
11
11
11
10
9
8
Total Equity
- -
- -
4.45
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
4.63
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
15.63
5.49
1
-112.07
-66.48
27.91
10.45
11
-44.69
-85.84
-16.82
9.97
-19.9
-144.3
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.84%
-6.88%
-10.48%
Free Cash Flow
55.61%
-92.31%
-183.62%
Net Income, GAAP
-86.36%
-61.8%
-53.94%
Sales/Revenue/Turnover
10.82%
14.19%
-2.87%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
12
2024
- -
- -
- -
- -
12
2025
- -
- -
- -
- -
12

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
-2.1
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Tivic Health Systems, Inc. (TIVC)
Qscreen Ai Inc. (PMEDF)
Positron Corporation (POSC)
Pheton Holdings Ltd Class A Ordinary Shares (PTHL)
AVRA Medical Robotics, Inc. (AVMR)
Coala-Life Group AB (publ) (COALA.ST)
Business
Surgical Innovations Group plc designs, develops, manufactures and sells medical devices for minimally invasive surgery and precision engineering applications; its core offerings include the Resposable YelloPort+ and YelloPortElite laparoscopic port access systems, Logi range of laparoscopic instruments, Logic reusable instruments, PretzelFlex organ and tissue retractor, LogiTube gastric calibration tubing for bariatric procedures, and Aspen portfolio products, alongside original equipment manufacturer services for bespoke medical devices and partnerships such as with DEAM for LaproFlex steerable instruments and CMR Surgical for hybrid ports. The company, founded in 1988 and headquartered in Leeds, United Kingdom, operates principally through its Surgical Innovations division with global distribution across Europe, the UK, USA, APAC and other regions, targeting hospitals and healthcare providers focused on sustainable keyhole surgery solutions that reduce costs by up to 58% per procedure and clinical waste by up to 85%. Recent developments encompass exclusive UK distribution agreements with Microline Surgical for five years and another partner for three years, robust 37% growth in SI branded products across key European markets in the first half of 2025 amid sustainability demand, introduction of the Aspen portfolio driving strong UK sales, ongoing cost-reduction initiatives delivering margin benefits from early 2026, and sustained investment in sales and R&D to support revenue expansion into 2026.